Kai Grass



Passionate about Healthcare, Corporate M&A and Divestitures with global experience in developed and emerging markets

About Kai


  • Interlock for M&A in Healthcare & Life Sciences
  • Co-author of Bain's 2023 M&A Report

Kai Grass is a member of our Healthcare & Life Sciences and M&A & Divestitures practices.

Kai’s healthcare work focuses on pharmaceutical and medtech clients. He has extensive experience in biopharma strategy and transformation in different topics such as R&D and clinical trials, M&A, commercial, pricing, and product launch, and emerging markets trends.

His recent client engagements have focused heavily on M&A and Divestiture topics for clients across industries. He is an authority on post-merger integration, carve-out/divestitures and separations, corporate M&A strategy and capability building, as well as value creation plans in post-acquisition situations.

Prior to joining the firm in 2009, he held research roles at Procter & Gamble and various academic institutions.

He holds a Ph.D. in Theoretical Physics from Goethe University, a diploma in physics from the University of Freiburg and a diploma in applied physics from the University of Auckland.

Recent Insights

Ready to talk?

We work with ambitious leaders who want to define the future, not hide from it. Together, we achieve extraordinary outcomes.